YCMGA
GHDX

York Capital Management Global Advisors’s Genomic Health, Inc. GHDX Stock Holding History

York Capital Management Global Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,370
Closed -$423K – 89
2017
Q4 		$423K Buy
+12,370
New +$394K 0.01% 70

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

York Capital Management Global Advisors's GHDX Position: Q1 2018 in Review

York Capital Management Global Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2018, closing a stake of 12,370 shares — an estimated $423K sold.

York Capital Management Global Advisors first reported a position in GHDX in Q4 2017 and held it in 1 quarter. The position peaked at $423K in Q4 2017. 134 funds tracked by Wall St. Rank hold GHDX as of Q1 2018.

  • York Capital Management Global Advisors reported no remaining Genomic Health, Inc. position as of Q1 2018 after selling out during the quarter.
  • York Capital Management Global Advisors sold 12,370 Genomic Health, Inc. shares in Q1 2018, an estimated $423K.
  • York Capital Management Global Advisors first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 1 quarter.
  • York Capital Management Global Advisors's Genomic Health, Inc. position peaked at $423K in Q4 2017.
  • 134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2018.

Based on York Capital Management Global Advisors's 13F filing for Q1 2018, filed 14 May 2018.